Best Medical Equipment Grants in Mississippi

The Clarence W. Winter Charitable Trust, established from Mr. Winter's Will, provides annual grants of $3,000 to $5,000 to support tax-exempt organizations focused on charitable, religious, scientific, literary, or educational purposes. While there are no geographic restrictions, the Trust prioritizes organizations in Bucks County, PA. With a commitment to community betterment, Mr. Winter's legacy continues to support impactful initiatives for years to come.

The Tuttleman Foundation, established in Philadelphia in 2003, provides grants ranging from $1,000 to $250,000 to 501c3 organizations. Guided by the legacy of Stanley and Edna Tuttleman, the foundation focuses on areas such as education, community building, health care, arts and museums, basic human services, and spirituality. Their engaged philanthropy aims to support enduring benefits for the communities they serve, reflecting the founders' commitment to impactful giving.

The HEAL Initiative aims to address the complex interplay between chronic pain and opioid use disorder (OUD), affecting 40-60% of OUD patients. Through the IMPOWR initiative, this funding opportunity seeks to develop integrated care strategies that enhance treatment delivery at health systems levels. By identifying effective interventions and collaborative care models, the initiative strives to improve patient outcomes in managing both chronic pain and OUD, while emphasizing the roles of various healthcare professionals in this integrated approach.

The Larry H. & Gail Miller Family Foundation offers General Operating Grants aimed at 501(c)(3) nonprofits that serve the west side of Salt Lake City. Grants of up to $10,000, with an average of $5,000, support initiatives in health, shelter, education, economic self-reliance, and cultural enrichment. Applications are reviewed monthly. Organizations must be registered as nonprofits and align with the Foundation's focus areas to be eligible for funding.

The J.R. Simplot Company Foundation Grant supports U.S. non-profit organizations focused on art, education, youth, community, and global food and agriculture. Established in 1929, the foundation is committed to enhancing community welfare through creative cultural endeavors, educational initiatives, health services, and youth programs. Applications are reviewed quarterly, ensuring a timely response to organizations dedicated to making a positive impact in their communities.

The Musicians Foundation Grant provides financial assistance to professional musicians in need, covering medical and dental bills, living expenses, and other essential costs during emergencies. Applicants must demonstrate at least five years of professional experience and apply for reasons beyond loss of work. The grants are issued as vendorized checks to ensure immediate support. This program is not designed for COVID-19 assistance or general income support, focusing instead on urgent hardship cases.

The Peyronie's Disease Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from Peyronie's disease. This condition involves the formation of fibrous scar tissue in the penis, leading to painful erections and erectile dysfunction. The fund provides financial assistance for prescription drugs and related healthcare costs, ensuring that patients receive necessary treatment without the stress of high out-of-pocket expenses. HealthWell is committed to improving access to essential healthcare for America’s underinsured population.

The Waldenstrom Macroglobulinemia Fund provides crucial financial assistance to underinsured patients suffering from this rare blood cancer. Through the HealthWell Foundation, the fund helps cover prescription copays, insurance premiums, and treatment-related costs, ensuring access to necessary medical care. With over $1.2 billion in grants awarded, the program has supported more than 1.1 million patients since its inception in 2004. Its mission is to alleviate financial barriers to essential healthcare, allowing patients to focus on their treatment and recovery.

The Systemic Sclerosis with Interstitial Lung Disease Fund, managed by the HealthWell Foundation, aims to reduce financial barriers for underinsured patients suffering from systemic sclerosis. This rare autoimmune disease leads to excessive collagen production, causing serious health issues. The fund assists with prescription copays and insurance premiums to ensure patients receive necessary treatments. In 2024, HealthWell awarded over $1.2 billion in grants, supporting more than 1.1 million patients in accessing vital healthcare services.

The Porphyrias Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from porphyrias, a group of eight disorders characterized by the accumulation of porphyrins in the body. The fund assists with prescription drug copays and insurance premiums, offering up to $4,000 in financial aid. Established to ensure no patient lacks necessary treatment due to costs, the foundation has awarded over $1.2 billion since 2004, supporting more than 1.1 million patients.

The Metabolic Dysfunction-Associated Steatohepatitis Fund, established by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients facing chronic illnesses. It provides critical support for expenses related to prescription copays, insurance premiums, and transportation for treatment. With a maximum award of $8,000, the fund ensures that individuals can access necessary healthcare services without financial strain. This initiative emphasizes the commitment to improving health outcomes for those affected by metabolic dysfunction-associated steatohepatitis.

The Mantle Cell Lymphoma Fund, managed by the HealthWell Foundation, provides financial assistance to underinsured patients diagnosed with Mantle Cell Lymphoma. The fund covers prescription drug copays and Medicare Part B premiums, with a maximum award of $8,500. Eligible patients must have insurance that covers their medication and meet specific income guidelines. The foundation aims to reduce financial barriers to essential treatments, ensuring that patients receive necessary care without undue financial strain.

The HealthWell Foundation's Inborn Metabolic or Genetic Bile Acid Deficiency Vitamins and Supplements Fund provides essential financial assistance for individuals facing significant health challenges. By covering copays, deductibles, and related expenses, the fund aims to alleviate the financial burden on underinsured patients. With a commitment to enhancing healthcare access, the Foundation has awarded over $1.2 billion since its inception, ensuring that vital treatments remain accessible to those in need.

The Hyperoxaluria Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from hyperoxaluria, a condition characterized by excessive oxalate in urine. This fund assists with prescription drug copays and insurance premiums, providing vital support for treatments. In 2024 alone, HealthWell allocated over $1.2 billion in grants, ensuring access to essential medications for those in need. The organization is committed to improving healthcare access and reducing disparities for affected individuals.

The Emergency/Medical Workers Behavioral Health Fund aims to support emergency workers facing trauma and anxiety due to their roles. Established by the HealthWell Foundation, it provides financial assistance for treatment-related costs, including copayments for prescription drugs, counseling, and transportation. In 2024, the Foundation awarded over $1.2 billion to underinsured patients, ensuring no one is denied essential healthcare due to financial barriers. This initiative helps address the critical mental health needs of those who serve on the front lines.

The Dupuytren’s Disease Fund, managed by the HealthWell Foundation, aims to reduce financial barriers for underinsured patients suffering from Dupuytren's Disease. This fund provides assistance for prescription drug copays and insurance premiums related to treatment. With an average grant utilization of $1,650 over a 12-month period, the fund ensures that essential medications and therapies are affordable. HealthWell Foundation, a private non-profit, has helped over 1.1 million patients since 2004, demonstrating its commitment to healthcare access.

The Cushing's Disease or Cushing's Syndrome Fund, operated by the HealthWell Foundation, provides vital financial assistance to underinsured patients facing high medical costs associated with these conditions. The fund covers co-payments, insurance premiums, and necessary treatments, ensuring that patients receive the care they need without financial burden. With an average grant utilization of $3,000 over twelve months, this fund aims to alleviate the challenges of treatment accessibility, supporting both physical and mental health for those affected.

Mississippi patients with congenital sucrase-isomaltase deficiency receiving treatment in the U.S. can get up to US $10,000 to offset prescription copays and Medicare Part B premiums. Healthwell Foundation support may ease costs for covered CSID medications, including sacrosidase, Sucraid, Nexium, and related treatments for digestive symptoms.

Underinsured U.S. patients being treated for chronic lymphocytic leukemia can receive up to US $8,000 to cover prescription drug copays and Medicare Part B premiums. With a mission to reduce financial barriers to care, Healthwell Foundation provides support that may ease treatment-related costs for Mississippi residents managing this disease.

Individuals in the U.S. receiving cancer-related behavioral health treatment can receive up to US $2,000 to cover prescription copays, counseling, psychotherapy, transportation, and related costs. HealthWell Foundation provides Mississippi patients and others with financial help when insurance leaves significant out-of-pocket expenses, supporting access to needed behavioral health care during cancer treatment.

Mississippi patients with blepharitis who are underinsured and receiving treatment in the U.S. can get help with prescription drug copays and Medicare Part B premiums through the Blepharitis Fund. Focused on health care access and delivery, Healthwell Foundation offers up to US $3,500 toward covered medications and related costs.

Patients in Mississippi needing help affording prescription drugs or Medicare Part B premiums for ANCA-associated vasculitis and granulomatosis with polyangiitis treatment can receive up to US $6,000 in assistance. Grants from HealthWell Foundation help cover copays and premiums for covered medications when patients are underinsured and meet medical, insurance, and income guidelines.

Individuals in Mississippi receiving treatment for amyotrophic lateral sclerosis (ALS) and facing high medical costs can get help with prescription drug copays and Medicare Part B premiums. With a mission to reduce financial barriers, HealthWell Foundation provides up to US $15,000 for underinsured U.S. patients whose income and insurance meet program guidelines.

Underinsured patients being treated for amyloidosis in Mississippi can receive up to US $8,000 to cover prescription drug copays and Medicare Part B insurance premiums through this national HealthWell Foundation fund. Eligible individuals must have insurance that covers their medication, meet income guidelines, and receive treatment in the U.S., which may ease costs for medical care and related needs.

Individuals with Alagille Syndrome receiving treatment in Mississippi and elsewhere in the U.S. can get help covering vitamins and supplements that support their care, with awards up to US $1,500. Grants from HealthWell Foundation assist underinsured patients by offsetting prescription copays for covered formulas, oral/tube feeding supplements, and specific vitamins to improve health care access and delivery.

The Neag Foundation Grant aims to foster positive change in education, healthcare, and the arts. Supporting initiatives in Pennsylvania and Connecticut, the foundation focuses on enhancing educational opportunities, advancing healthcare interventions, and promoting the arts and humanities. By encouraging innovative projects that receive community support, it seeks to improve the quality of life for individuals and families. Organizations with a 501(c)(3) status are encouraged to apply for funding opportunities that align with these goals.

The Pharmacy Leadership Scholars program, offered by the ASHP Research and Education Foundation, is a competitive grant initiative aimed at early-stage pharmacist researchers focusing on diversity, equity, and inclusion (DEI) in healthcare. With funding of up to five $10,000 grants, this program fosters collaboration and leadership development among grantees. It encourages innovative research addressing DEI gaps, aiming to empower pharmacists to enhance healthcare access and quality for diverse populations. This initiative is pivotal for shaping future leaders in pharmacy.